Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1131350

CC[n+]1ccn(C)c1.Cl.Cl.[AlH3]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003500460-A 2003-01-07 JP claimed
US-20020056633-A1 Preparation and use of ionic liquids in microwave-assisted chemical transformations BIOTAGE AB (SE) 2002-05-16 US claimed
EP-1194227-A1 PREPARATION AND USE OF IONIC LIQUIDS IN MICROWAVE-ASSISTED CHEMICAL TRANSFORMATIONS Personal Chemistry i Uppsala AB (SE) 2002-04-10 EP claimed
WO-2000072956-A1 PREPARATION AND USE OF IONIC LIQUIDS IN MICROWAVE-ASSISTED CHEMICAL TRANSFORMATIONS PERSONAL CHEMISTRY I UPPSALA AB (SE) 2000-12-07 WO claimed
US-20230313072-A1 Composite Form of Tetraacetylenediamine ONE1STAR SOLUTIONS LIMITED (GB) 2023-10-05 US disclosed
CN-116075497-A Composite forms of tetraacetylethylene diamine 一星解决方案有限公司 2023-05-05 CN disclosed
CN-105806799-B Use the method for vibrational spectrum monitoring ionic liquid 雪佛龙美国公司 2018-11-23 CN disclosed
US-7939485-B2 Benefit agent delivery system comprising ionic liquid THE PROCTER & GAMBLE COMPANY (US) 2011-05-10 US disclosed
US-7928053-B2 Multiphase cleaning compositions having ionic liquid phase THE PROCTER & GAMBLE COMPANY (US) 2011-04-19 US disclosed
EP-1517982-B1 IONIC LIQUID BASED PRODUCTS AND METHOD OF USING THE SAME PROCTER & GAMBLE (US) 2011-02-16 EP disclosed
US-7776810-B2 ionic liquid active composed of an ion active bis/fatty ester ethyl-(dimethylammonium)cation and an ionic liquid-forming counter ion containing 1,1,1-trifluoro-N-[(trifluoromethyl) sulfonyl] methanesulfonamidinate; capable of deivering surface treatment, air treatment and fabric treatment benifits THE PROCTER & GAMBLE COMPANY (US) 2010-08-17 US disclosed
US-20090233829-A1 MULTIPHASE CLEANING COMPOSITIONS HAVING IONIC LIQUID PHASE HECHT STACIE ELLEN 2009-09-17 US disclosed
US-20060090777-A1 Multiphase cleaning compositions having ionic liquid phase THE PROCTER & GABMLE COMPANY 2006-05-04 US disclosed
US-20060094620-A1 Compositions containing ionic liquid actives PROCTER & GAMBLE COMPANY, THE 2006-05-04 US disclosed
EP-1194227-B1 PREPARATION AND USE OF IONIC LIQUIDS IN MICROWAVE-ASSISTED CHEMICAL TRANSFORMATIONS BIOTAGE AB (SE) 2004-09-15 EP disclosed
US-20040077519-A1 Ionic liquid based products and method of using the same THE PROCTER & GAMBLE CO. 2004-04-22 US disclosed
US-6596130-B2 Using ionic liquids as solvents resulted in high yields with dramatically reduced reaction times PERSONAL CHEMISTRY I UPPSALA AB (SE) 2003-07-22 US disclosed
US-20020056633-A1 Preparation and use of ionic liquids in microwave-assisted chemical transformations BIOTAGE AB (SE) 2002-05-16 US disclosed
EP-1194227-A1 PREPARATION AND USE OF IONIC LIQUIDS IN MICROWAVE-ASSISTED CHEMICAL TRANSFORMATIONS Personal Chemistry i Uppsala AB (SE) 2002-04-10 EP disclosed
WO-2000072956-A1 PREPARATION AND USE OF IONIC LIQUIDS IN MICROWAVE-ASSISTED CHEMICAL TRANSFORMATIONS PERSONAL CHEMISTRY I UPPSALA AB (SE) 2000-12-07 WO disclosed